Skip to main content

Commentary: sex difference differences? A reply to Constantino

Abstract

Messinger et al. found a 3.18 odds ratio of male to female ASD recurrence in 1241 prospectively followed high-risk (HR) siblings. Among high-risk siblings (with and without ASD), as well as among 583 low-risk controls, girls exhibited higher performance on the Mullen Scales of Early Learning, as well as lower restricted and repetitive behavior severity scores on the Autism Diagnostic Observation Schedule (ADOS) than boys. That is, female-favoring sex differences in developmental performance and autism traits were evident among low-risk and non-ASD high-risk children, as well as those with ASD. Constantino (Mol Autism) suggests that sex differences in categorical ASD outcomes in Messinger et al. should be understood as a female protective effect. We are receptive to Constantino’s (Mol Autism) suggestion, and propose that quantitative sex differences in autism-related features are keys to understanding this female protective effect.

Background

Prospective studies of the high-risk siblings of children with ASD offer an opportunity to examine both sex differences in ASD occurrence and sex differences in ASD traits and related cognitive characteristics. Messinger et al. [1] reported on a large sample (1241 high-risk siblings and 583 low-risk children) recruited at a mean age of 7.25 months, whose cognitive/developmental performance on the Mullen Scales of Early Learning (MSEL) and autism severity scores on the Autism Diagnostic Observation Schedule (ADOS) were assessed at 24 and 36 months. ASD outcome (assessed at 36 months) required both a clinical best estimate diagnosis of ASD as well as an ADOS severity score ≥4.

The female protective effect may be operationalized with respect to the Carter effect, which holds that siblings of female ASD probands will evidence greater ASD affectation (more severe autism traits) than siblings of male probands [2, 3]. This argument has been buttressed by findings of increased genetic liability (e.g., deleterious copy number variants and single-nucleotide variants) in female ASD probands [4]. However, Messinger et al. found that the high-risk siblings of female ASD probands did not differ significantly in ASD outcome, Mullen performance, or severity scores from siblings of male ASD probands. In other words, proband sex was not consequential for the younger high-risk sibling’s outcome.

Constantino suggests that sex differences in categorical ASD clinical outcomes among the high-risk siblings themselves should be understood as a female protective effect [5]. We are open to this formulation. Quantifying sex differences in categorical ASD outcome is important to understanding the female protective effect. The male to female odds ratio for ASD outcome in Messinger et al. was 3.18, similar to that reported in population-based studies of affected children [6, 7]. The accompanying commentary ([5], see Fig. 1) noted that there were over three times more ASD outcomes among male (193) than female (59) HR siblings. This is correct, but does not reflect the higher absolute number of male HR siblings. The proportion of HR siblings with ASD outcomes was .27 (193/714) for males and .11 (59/527) for females (see Fig. 1).

Fig. 1
figure 1

ASD symptoms and ASD recurrence by sex in high-risk siblings with and without ASD. Horizontal lines indicate differences between male and female high-risk siblings in ADOS Restricted and Repetitive Behavior (RRB) severity scores [1]. The vertical arrows connect high-risk No-ASD and to high-risk ASD groups (see Constantino, 2016, Figure 1). The widths of the upward arrows reflect the proportion of high-risk males (.27) and the proportion of HR females (.11) with an ASD outcome. These proportions are also reflected in the width of the horizontal lines of male and female ASD groups

Messinger et al. found that the under-representation of female categorical ASD outcomes was accompanied by female-favoring sex differences in quantitatively distributed ASD-relevant behaviors [1]. Figure 1 displays restricted and repetitive behavior severity scores from the ADOS, which provide a context for visualizing differences among high-risk siblings in categorical ASD outcomes. Among HR-ASD and HR No-ASD siblings, as well as among LR infants, girls exhibited both higher levels of cognitive/developmental performance and lower levels of restricted and repetitive behaviors than boys. Sex differences, while smaller than the differences between high-risk siblings with and without ASD, were characterized by medium to large effect sizes. An absence of group by sex interaction effects indicated that sex differences in children with ASD were not autism specific; they were also evident in high-risk siblings without ASD and low-risk children.

Overall decrements in quantitative indices of autistic traits among females are common in high-risk siblings with and without ASD [811] as well as in the general population [12]. It is likely that population-level reductions in ASD-relevant traits among females lower the propensity for ASD occurrence among females. While certainly not a full explanation for higher rates of ASD among males, sex differences in ASD-relevant traits are pertinent to and, in fact, may be manifestations of a female protective effect.

Conclusions

The relationship between sex differences in quantitative autistic traits and categorical ASD outcomes involves examination of commonalities and differences in the presentation and causes of ASD in males and females [1315]. While quantitative and categorical outcomes were not independent in Messinger et al., the large scale prospective results indicate both a robust female advantage in most but not all autism-related traits, and a threefold reduction in female ASD outcomes. Ultimately, a female protective effect manifested in a lower rate of categorical ASD outcomes must be informed by a thorough understanding of female-favoring sex differences in quantitative ASD traits.

Abbreviations

ADOS, autism diagnostic observation schedule; ASD, autism spectrum disorder; BSRC, Baby Siblings Research Consortium; HR No-ASD, high-risk group without ASD outcomes; HR, high-risk group; HR-ASD, high-risk group with ASD outcomes; LR, low risk group; MSEL, Mullen scales of early learning; RRB, Restricted and Repetitive Behavior Domain Calibrated Severity Score from the Autism Diagnostic Observation Schedule

References

  1. Messinger DS et al. Early sex differences are not autism-specific: a Baby Siblings Research Consortium (BSRC) study. Mol Autism. 2015;6:32.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Robinson EB et al. Examining and interpreting the female protective effect against autistic behavior. Proc Natl Acad Sci U S A. 2013;110(13):5258–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Jacquemont S et al. A higher mutational burden in females supports a “female protective model” in neurodevelopmental disorders. Am J Hum Genet. 2014;94(3):415–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Jacquemont S, Coe BP, Hersch M, Duyzend MH, Krumm N, Bergmann S, Eichler EE (2014). A higher mutational burden in females supports a "female protective model" in neurodevelopmental disorders. Am J Hum Genet. 2014;94(3):415-425. doi: 10.1016/j.ajhg.2014.02.001

  5. Constantino JN. Data from the Baby Siblings Research Consortium confirm and specify the nature of the female protective effect in autism: a commentary on Messinger et al. Mol Autism. 2016. In press.

  6. Kim YS et al. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry. 2011;168(9):904–12.

    Article  PubMed  Google Scholar 

  7. Idring S et al. Autism spectrum disorders in the Stockholm youth cohort: design, prevalence and validity. PLoS ONE. 2012;7(7):e41280.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Virkud YV et al. Familial aggregation of quantitative autistic traits in multiplex versus simplex autism. Am J Med Genet B Neuropsychiatr Genet. 2009;150b(3):328–34.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Hartley SL, Sikora DM. Sex differences in autism spectrum disorder: an examination of developmental functioning, autistic symptoms, and coexisting behavior problems in toddlers. J Autism Dev Disord. 2009;39(12):1715–22.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Szatmari P et al. Sex differences in repetitive stereotyped behaviors in autism: implications for genetic liability. Am J Med Genet B Neuropsychiatr Genet. 2012;159b(1):5–12.

    Article  PubMed  Google Scholar 

  11. Frazier TW, Georgiades S, Bishop SL, Hardan AY. (2014). Behavioral and cognitive characteristics of females and males with autism in the Simons Simplex Collection. J Am Acad Child Adolesc Psychiatry. 2014;53(3):329-340.e321-323. doi: 10.1016/j.jaac.2013.12.004

  12. Constantino JN, Todd RD. Intergenerational transmission of subthreshold autistic traits in the general population. Biol Psychiatry. 2005;57(6):655–60.

    Article  PubMed  Google Scholar 

  13. Russell G, Steer C, Golding J. Social and demographic factors that influence the diagnosis of autistic spectrum disorders. Soc Psychiatry Psychiatr Epidemiol. 2011;46(12):1283–93.

    Article  PubMed  Google Scholar 

  14. Lai M et al. Sex/gender differences and autism: setting the scene for future research. J Am Acad Child Adolesc Psychiatry. 2015;54(1):11–24.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Robinson EB et al. Genetic risk for autism spectrum disorders and neuropsychiatric variation in the general population. Nat Genet. 2016. Advance online publication.

Download references

Acknowledgements

Not applicable.

Funding

Autism Speaks provided support for the creation of the Baby Siblings Research Consortium (BSRC) Database. Data collection, analyses, and manuscript preparation were supported by the National Institutes of Health (C.A.N. R01DC010290; D.M. R01HD057284; D.M. R01GM105004; H.T.F. R01DC010290; H.T.F.R21DC008637; K.C. R01MH087554; K.C. PO1HD003008, Project 1; J.M.I. R01HD054979; R.L. R01MH059630; S.O R01MH068398; S.J.W. P50HD055782; S.J.W. R01HD064820; T.H. K01MH096961; T.H. U54 MH068172; T. H. P50 HD55784; W.L.S. R01HD057284); the Canadian Institutes of Health Research (S.B., L.Z.); the UK Medical Research Council (T.C.); NeuroDevNet (S.B., L.Z.), Autism Speaks Canada (S.B., L.Z.); Autism Speaks [U.S.] Pilot Grant (H.T.F., J.M.I.); Autistica (T.C.); the FAR Fund (K.C.); and the Simons Foundation (C.A.N.).

Availability of data and materials

Not applicable.

Authors’ contributions

DSM drafted the manuscript and GSY created Fig. 1. SJW, SO, SB, AC, LC, TC, KC, SC, KD, IH-P, TH, JMI, RL, CAN, WLS, HT-F, and LZ edited or provided feedback on the manuscript. All authors read and approved the manuscript.

Competing interests

Dr. Zwaigenbaum receives operating funds but not honoraria from SynapDx. Dr. Charman receives royalties from Guilford Press and Sage Publications. Drs. Bryson, Carter, Carver, Chawarska, Dobkins, Iverson, Landa, Hutman, Messinger, Nelson, Ozonoff, Stone, Tager-Flusberg, Webb, and Young declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel S. Messinger.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Messinger, D.S., Young, G.S., Webb, S.J. et al. Commentary: sex difference differences? A reply to Constantino. Molecular Autism 7, 31 (2016). https://doi.org/10.1186/s13229-016-0093-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13229-016-0093-9

Keywords